Porcine Segment has the Largest Share of Raw Material in the Middle East & Africa Extracellular Matrix Market during 2021–2028

According to our latest study on “Middle East & Africa Extracellular Matrix Market Forecast to 2028 – COVID-19 Impact and Analysis – by Raw Material, and Application,” the market is projected to reach US$ 2,278.4 Thousands by 2028 from US$ 1,485.2 Thousands in 2021; it is expected to grow at a CAGR of 6.3% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the significantly are increasing incidences of trauma and cardiovascular diseases and increasing vascular reconstruction procedures. However, challenges during the usage of decellularized extracellular matrix are expected to restrict the market growth during the forecast period.

The pandemic has increased demand for medical devices, which can used in-home care. The region is witnessing an increase in the number of patients being admitted to intensive care units (ICU), an increasing number of drugs that pose multiple diagnostic and therapeutic challenges to strained health systems, leading to an increase in medical devices. There have been changes in staff assignments and working hours and the implementation of strict infection control and social distancing measures. In addition, they also face mental, physical, emotional, and financial challenges. COVID-19 does not currently have any specific antiviral drug treatment, so treatment for the disease is mainly focused on symptomatic treatment and oxygen therapy. It is recommended that inflammatory factors and lymphocyte subsets be monitored throughout the illness. Current treatment of severe type and critical type COVID-19 patients in the Middle East and Africa is key to controlling the rising number of deaths. The government is currently engaged in several efforts to discover, repurpose, and/or develop preventive and treatment options for COVID-19. The pharmaceutical industry in Sub-Saharan Africa is poorly developed and cannot effectively meet the prevention and treatment needs of the region for the biomedical management of COVID-19.

Based on raw materials, the Middle East & Africa extracellular matrix market is bifurcated into bovine, porcine, and others. In 2021, the porcine segment is likely to account for the largest share of the market. However, the bovine segment is estimated to register the highest CAGR during the forecast period. Extracellular matrix made of porcine are derived from porcine adipose tissue, urinary bladder, or mammary fatty tissues. The most common parts of pigs such as skin and bones are used to derive extracellular matrix. The extracellular matrix derived from skin and bone are commonly used for the industrial purpose. Porcine collage is almost similar to human collagen, and it does not cause allergic response when used.

Medtronic, Merck Kgaa, Smith & Nephew, Coloplast Group, Baxter, DSM, and Cook Biotech are among the leading companies in the Middle East & Africa extracellular matrix market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for extracellular matrix market is segmented into raw material, and application. Based on raw material, the Middle East & Africa extracellular matrix market is segmented into bovine, porcine, and others. Based on application, the extracellular matrix market is segmented into soft tissue repair, dural repair, wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. Geographically, the extracellular matrix market is segmented into Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa).

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com